Iron Triangle Partners LP's Q4 2023 13F: 10 new positions, 7 exits
Form 13F-HR for the quarter ended Dec 31, 2023 · filed Feb 14, 2024 · 26 reported positions · accession 0001172661-24-001531
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| Exited | UNITED THERAPEUTICS CORP DEL (UTHR) | 7.0% | — | −7.0 pts | −211K sh | −100% |
| New | IDEXX LABS INC (IDXX) | — | 5.5% | +5.5 pts | +76,025 sh | new |
| Exited | APELLIS PHARMACEUTICALS INC (APLS) | 4.9% | — | −4.9 pts | −880K sh | −100% |
| Reduced | DEXCOM INC (DXCM) | 7.7% | 4.7% | −3.1 pts | −276K sh | −49% |
| New | SURGERY PARTNERS INC (SGRY) | — | 4.3% | +4.3 pts | +1.04M sh | new |
| New | ILLUMINA INC (ILMN) | — | 4.0% | +4.0 pts | +220K sh | new |
| New | INSPIRE MED SYS INC (INSP) | — | 3.9% | +3.9 pts | +150K sh | new |
| Reduced | UNIVERSAL HLTH SVCS INC (UHS) | 9.2% | 6.3% | −2.9 pts | −180K sh | −36% |
| New | SANOFI (SNY) | — | 3.2% | +3.2 pts | +500K sh | new |
| Exited | BOSTON SCIENTIFIC CORP (BSX) | 3.1% | — | −3.1 pts | −400K sh | −100% |
| Exited | INTRA-CELLULAR THERAPIES INC (ITCI) | 2.5% | — | −2.5 pts | −331K sh | −100% |
| New | BIOMARIN PHARMACEUTICAL INC (BMRN) | — | 2.5% | +2.5 pts | +200K sh | new |
| Exited | EXACT SCIENCES CORP (EXAS) | 2.5% | — | −2.5 pts | −250K sh | −100% |
| New | OSCAR HEALTH INC (OSCR) | — | 2.4% | +2.4 pts | +2.05M sh | new |
| New | SCHRODINGER INC (SDGR) | — | 2.2% | +2.2 pts | +469K sh | new |
| New | REPLIGEN CORP (RGEN) | — | 1.9% | +1.9 pts | +82,537 sh | new |
| Reduced | GLAUKOS CORP (GKOS) | 4.7% | 2.5% | −2.2 pts | −185K sh | −43% |
| New | TEVA PHARMACEUTICAL INDS LTD (TEVA) | — | 1.8% | +1.8 pts | +1.3M sh | new |
| Exited | OLINK HLDG AB (OLK) | 1.6% | — | −1.6 pts | −738K sh | −100% |
| Increased | ICON PLC (ICLR) | 4.7% | 6.3% | +1.6 pts | +42,675 sh | +33% |
| Reduced | 10X GENOMICS INC (TXG) | 4.0% | 3.5% | −0.5 pts | −188K sh | −28% |
| Reduced | INTUITIVE SURGICAL INC (ISRG) | 6.1% | 5.2% | −0.8 pts | −22,000 sh | −15% |
| Reduced | ESTABLISHMENT LABS HLDGS INC (ESTA) | 4.1% | 1.1% | −3.0 pts | −239K sh | −42% |
| Reduced | ELANCO ANIMAL HEALTH INC (ELAN) | 5.6% | 5.8% | +0.2 pts | −412K sh | −12% |
| Increased | MCKESSON CORP (MCK) | 4.4% | 4.8% | +0.3 pts | +10,000 sh | +14% |
| Reduced | LEGEND BIOTECH CORP (LEGN) | 4.4% | 3.0% | −1.5 pts | −72,629 sh | −16% |
| Exited | SPRINGWORKS THERAPEUTICS INC (SWTX) | 0.5% | — | −0.5 pts | −150K sh | −100% |
| Increased | BROOKDALE SR LIVING INC (BKD) | 2.6% | 3.7% | +1.1 pts | +623K sh | +15% |
| Increased | 908 DEVICES INC (MASS) | 1.0% | 1.9% | +0.9 pts | +304K sh | +31% |
| Increased | ACADIA HEALTHCARE COMPANY IN (ACHC) | 7.9% | 8.0% | +0.1 pts | +26,789 sh | +4% |
| Increased | BRUKER CORP (BRKR) | 3.9% | 4.3% | +0.4 pts | +19,157 sh | +4% |
| Increased | PACIFIC BIOSCIENCES CALIF IN (PACB) | 2.2% | 2.3% | +0.1 pts | +43,278 sh | +2% |
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 55.9% of the equity book
Changes in the top 10 this quarter: IDXX entered · MCK entered · SGRY entered · UTHR left · APLS left · GKOS left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | ACADIA HEALTHCARE COMPANY IN (ACHC) | 7.9% | 8.0% | |
| 2 | UNIVERSAL HLTH SVCS INC (UHS) | 9.2% | 6.3% | |
| 3 | ICON PLC (ICLR) | 4.7% | 6.3% | |
| 4 | ELANCO ANIMAL HEALTH INC (ELAN) | 5.6% | 5.8% | |
| 5 | IDEXX LABS INC (IDXX) | 0.0% | 5.5% | Entered the top 10 |
| 6 | INTUITIVE SURGICAL INC (ISRG) | 6.1% | 5.2% | |
| 7 | ABBVIE INC (ABBV) | 5.4% | 5.0% | |
| 8 | MCKESSON CORP (MCK) | 4.4% | 4.8% | Entered the top 10 |
| 9 | DEXCOM INC (DXCM) | 7.7% | 4.7% | |
| 10 | SURGERY PARTNERS INC (SGRY) | 0.0% | 4.3% | Entered the top 10 |
| — | UNITED THERAPEUTICS CORP DEL (UTHR) | 7.0% | 0.0% | Left the top 10 |
| — | APELLIS PHARMACEUTICALS INC (APLS) | 4.9% | 0.0% | Left the top 10 |
| — | GLAUKOS CORP (GKOS) | 4.7% | 2.5% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).